Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models-Reference-Cited by-同舟云学术

Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models

Published:2022-03 Issue: Volume:24 Page:452-466
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Ko Dongjoon^ORCID,Kim Eunmi,Shin Eun-Ae,Nam Seo Hee,Yoon Junghwa,Lee Jin-Sook,Lee Yunhee,Park Sora,Ha Kyungsoo,Choi So-Young,Lee Jung Weon^ORCID,Kim Semi^ORCID

Funder

National Research Foundation of Korea

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference37 articles.

1. Estimating the globalcancer incidence and mortality in 2018: GLOBOCAN sources and methods;Ferlay;Int. J. Cancer,2019

2. Liver cancer: approaching a personalized care;Bruix;J. Hepatol.,2015

3. New insights into sorafenib resistance in hepatocellular carcinoma: responsible mechanisms and promising strategies;Niu;Biochim. Biophys. Acta Rev. Cancer,2017

4. Comprehensive review of targeted therapy for colorectal cancer;Xie;Signal Transduct. Target. Ther.,2020

5. Targeting tetraspanins in cancer;Sala-Valdes;Expert Opin. Ther. Targets,2012

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multi-omics analysis revealed the regulation mode of intratumor microorganisms and microbial signatures in gastrointestinal cancer;Carcinogenesis;2023-11-07

2. Determination of Eight Hub Genes and Functional Pathways Affecting both the Survival of Early- and Late-Stage Colon Cancer Patients;Turkish Journal of Oncology;2023

3. Systemic TM4SF5 overexpression in Apc^Min/+ mice promotes hepatic portal hypertension associated with fibrosis;BMB Reports;2022-12-31

4. TM4SF5-Mediated Regulation of Hepatocyte Transporters during Metabolic Liver Diseases;International Journal of Molecular Sciences;2022-07-29